Combination chemotherapy with ifosfamide, cisplatin, and etoposide for medulloblastoma: Single-institute experience and differences in efficacy for subgroups of medulloblastoma

Child's Nervous System

Volumn 27, Issue 9, 2011, Pages 1399-1406

  Saito, Ryuta ^a   Kumabe, Toshihiro ^a   Sonoda, Yukihiko ^a   Kanamori, Masayuki ^a   Yamashita, Yoji ^a   Watanabe, Mika ^b   Tominaga, Teiji ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

ICE chemotherapy; Immunohistochemistry; Medulloblastoma; Overall survival; Progression free survival; Radiotherapy

Indexed keywords

CISPLATIN; ETOPOSIDE; IFOSFAMIDE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; HEARING DISORDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; INFECTION; MALE; MEDULLOBLASTOMA; MULTIMODALITY CANCER THERAPY; NEUROPATHY; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; SIDE EFFECT; SODIUM BLOOD LEVEL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CISPLATIN; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; INFANT; MALE; MEDULLOBLASTOMA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80054718820     PISSN: 02567040     EISSN: 14330350     Source Type: Journal    
DOI: 10.1007/s00381-011-1485-y     Document Type: Article

References (13)

1. Crawford JR MacDonald TJ, Packer RJ (2007) Medulloblastoma in childhood: new biological advances. Lancet Neurol6:1073-1085 (Pubitemid 350116703)
2. Deutsch M, Thomas PR, Krischer J, Boyett JM, Albright L, Aronin P, Langston J, Allen JC, Packer RJ, Linggood R, Mulhern R, Stanley P, Stehbens JA, Duffner P, Kun L, Rorke L, Cherlow J, Freidman H, Finlay JL, Vietti T (1996) Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A combined Child-ren's Cancer Group-Pediatric Oncology Group Study. Pediatr Neurosurg 24:167-176
3. Giangaspero F, Eberhart CG, Haapasalo H, Pietsch T, Wiestler OD, Ellison DW (2007) Medulloblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC, Lyon, pp 132-140
4. Jakacki RI (2005) Treatment strategies for high-risk medulloblas-toma and supratentorial primitive neuroectodermal tumors. Re-view of the literature. J Neurosurg 102(1 Suppl):44-52 (Pubitemid 44955009)
5. Kochi M, Kuratsu J, MiharaY, Takaki S, Seto H, Uemura S, Ushio Y (1993) Ventriculolumbar perfusion of3-[(4-amino-2-methyl-5-pyr-imidinyl)methyl]-1-(2- chloroethyl)-1-nitrosourea hydrochloride. Neurosurgery 33:817-823
6. Kortmann RD, Kühl J, Timmermann B, Mittler U, Urban C, Budach V, Richter E, Willich N, Flentje M, Berthold F, Slavc I, Wolff J, Meisner C, Wiestler O, Sörensen N, Warmuth-Metz M, Bamberg M (2000) Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 46:269-279 (Pubitemid 30067775)
7. Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart C, Mack S, Bouffet E, Clifford SC, Hawkins C, French P, Rutka JT, Pfister S, Taylor MD (2011) Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 29(11):1408-1414
8. Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, Muraszko K, Langston J, Sposto R (2006) Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 24:4202-4208 (Pubitemid 46622300)
9. Packer RJ, Goldwein J, Nicholson HS, Vezina LG, Allen JC, Ris MD, Muraszko K, Rorke LB, Wara WM, Cohen BH, Boyett JM (1999) Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group Study. J Clin Oncol 17:2127-2136 (Pubitemid 29318845)
10. Packer RJ, Sutton LN, Goldwein JW, Perilongo G, Bunin G, Ryan J, Cohen BH, D'Angio G, Kramer ED, Zimmerman RA, Rorke LB, Evans AE, Schut L (1991) Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74:433-440
11. Packer RJ, Vezina G (2008) Management of and prognosis with medulloblastoma: therapy at a crossroads. Arch Neurol 65:1419-1424
12. Sawamura Y, Ikeda J, Ishii N, Kato T, Tada M, Abe H, Shirato H (1996) Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/ posterior fossa primitive neuroectodermal tumor-results of a pilot study. Neurol Med Chir Tokyo 36:632-638 (Pubitemid 26321571)
13. Thomas PR, Deutsch M, Kepner JL, Boyett JM, Krischer J, Aronin P, Albright L, Allen JC, Packer RJ, Linggood R, Mulhern R, Stehbens JA, Langston J, Stanley P, Duffner P, Rorke L, Cherlow J, Friedman HS, Finlay JL, Vietti TJ, Kun LE (2000) Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 18:3004-3011 (Pubitemid 30644125)